News Conference News HRS 2020 Permanent Conduction-System Pacing After TAVR? Don’t ‘Diss the His’ Michael O'Riordan May 21, 2020
News Conference News HRS 2020 Subcutaneous ICD Holds Up Well Against Transvenous Devices Todd Neale May 13, 2020
News Conference News ACC 2020 Ischemia Burden Not Linked to Angina in Nonobstructive CAD: CIAO Michael O'Riordan March 31, 2020
News Conference News ACC 2020 ISCHEMIA in Print: New MI Data and More Calls for Longer Follow-up Shelley Wood March 30, 2020
News Conference News ACC 2020 A Win for Vericiguat in High-Risk Chronic HF Patients: VICTORIA Michael O'Riordan March 28, 2020
News Conference News ACC 2020 Statins May Have Protective Effect on Chemotherapy-Induced Cardiotoxicity Yael L. Maxwell March 19, 2020
News Conference News CRT 2020 Good Coronary Collateral Circulation? Better LVEF and Survival After STEMI Michael O'Riordan February 24, 2020
News Conference News PCR London Valves 2019 Pulmonary Hypertension, Common in TAVR Patients, Linked to Lower Survival Michael O'Riordan November 26, 2019
News Conference News AHA 2019 Sex Differences, EF Thresholds Probed for Sacubitril/Valsartan in Heart Failure Shelley Wood November 22, 2019
News Conference News AHA 2019 Dapagliflozin Has Benefits Across Heart Failure Subgroups Todd Neale November 17, 2019
News Conference News AHA 2019 ISCHEMIA: Invasive Strategy No Better Than Meds for CV Events Shelley Wood November 16, 2019
News Conference News TCT 2019 TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3 Yael L. Maxwell September 29, 2019
News Conference News TCT 2019 Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR Todd Neale September 29, 2019
News Conference News HFSA 2019 Virtual Doctor Visits Reduce Missed Appointments After HF Hospitalizations: ViV-HF L.A. McKeown September 23, 2019
News Conference News HFSA 2019 New PROVE-HF Data May Reassure Clinicians of Sacubitril/Valsartan Benefit in HFrEF L.A. McKeown September 18, 2019
News Conference News HFSA 2019 DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF L.A. McKeown September 16, 2019
News Conference News ESC 2019 Primary Prevention ICDs Still Render Better Survival, Even in Modern HFrEF Patients Todd Neale September 13, 2019
News Conference News ESC 2019 Beta-blockers Safe, Effective for HFrEF Patients With Renal Dysfunction: Meta-analysis Yael L. Maxwell September 12, 2019
News Conference News ESC 2019 Young MI Patients’ Ischemic Risk Extends at Least Two Decades Caitlin E. Cox September 06, 2019
News Conference News ESC 2019 Stopped Early, DAPA Offers Insight on ICD Timing After STEMI Shelley Wood September 04, 2019